Alnylam Pharmaceuticals Inc (ALNY)
BMV
Closed
Aug 21, 2026
Day's Range
5,549.0052 wk Range
5,150.16Overview - ALNY - Alnylam Pharmaceuticals Inc
Key Statistics
Valuation
Enterprise Value
12.54T
P/E (Trailing)
‪57.14‬
PEG Ratio
‪-0.16‬
Price / Sales (TTM)
‪154.55‬
Price / Book
‪32.32‬
EV / EBITDA
‪703.80‬
Profitability
Gross Margin
‪76.88%‬
Profit Margin
‪16.12%‬
Operating Margin
‪17.92%‬
Return on Assets
‪12.34%‬
Return on Equity
‪96.55%‬
Ownership
Shares Outstanding
133.73M
Float
133.23M
Held by Insiders
‪0.18%‬
Held by Institutions
‪101.71%‬
Price stats
Beta
‪0.27‬
50-Day Avg
‪5,413.39‬
200-Day Avg
‪7,206.45‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ALNY - Alnylam Pharmaceuticals Inc
Peers - ALNY - Alnylam Pharmaceuticals Inc
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.33P/E (Trailing)‪32.26%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.218.20BMarket Cap+4.43%52-week change192.34P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.46P/E (Trailing)‪33.41%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
- ARWRBMVArrowhead Pharmaceuticals Inc.64.20BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
Profile Summary - ALNY - Alnylam Pharmaceuticals Inc
About
Alnylam Pharmaceuticals Inc is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of therapeutics based on RNA interference technology. The company focuses on treating genetically defined and other hard-to-treat diseases by silencing specific genes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
